Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration.
Cotton
D
D
D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D053626:Atovaquone; D001682:Biological Availability; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D009285:Naphthoquinones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D009285:Naphthoquinones; D053626:Atovaquone